KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Royalty Pharma (RPRX) over the last 6 years, with Q3 2025 value amounting to 0.12.

  • Royalty Pharma's Asset Utilization Ratio fell 172.71% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year decrease of 172.71%. This contributed to the annual value of 0.13 for FY2024, which is 777.9% down from last year.
  • Royalty Pharma's Asset Utilization Ratio amounted to 0.12 in Q3 2025, which was down 172.71% from 0.13 recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Asset Utilization Ratio registered a high of 0.15 during Q4 2023, and its lowest value of 0.12 during Q3 2025.
  • Its 5-year average for Asset Utilization Ratio is 0.13, with a median of 0.13 in 2022.
  • Per our database at Business Quant, Royalty Pharma's Asset Utilization Ratio skyrocketed by 1258.62% in 2023 and then plummeted by 1454.08% in 2024.
  • Royalty Pharma's Asset Utilization Ratio (Quarter) stood at 0.13 in 2021, then dropped by 0.12% to 0.13 in 2022, then rose by 12.59% to 0.15 in 2023, then fell by 14.54% to 0.12 in 2024, then decreased by 0.06% to 0.12 in 2025.
  • Its last three reported values are 0.12 in Q3 2025, 0.13 for Q2 2025, and 0.13 during Q1 2025.